Patent · US Active

Biological marker for evaluating the IL-17 pro-inflammatory functional contribution dependent level in an individual

US11079391B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignees

HOSPICES CIVILS DE LYON · FR
UNIVERSITE CLAUDE BERNAD LYON 1 · FR

Inventors

Pierre Miossec · Bron, FR
Ndieme THIAM · Val-de-Reuil, FR

Key dates

Filing date	Jun 5, 2015
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Jul 6, 2037

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/7095
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention relates to an in vitro process for determining the functional IL-17 pro-inflammatory dependent level (IPDL) of a biological sample, comprising the following steps:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.